Company
Helsinn Hlthcare
Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
5
2 still marketed
Novel approvals
4
Approvals since 2021
1
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Truseltiq approved NovelAccelerated approvalPriority reviewOrphanMay 28, 2021
- Akynzeo approved NovelApr 19, 2018
- Akynzeo approved NovelOct 10, 2014
- Aloxi new use Priority reviewMay 27, 2014
- Aloxi new use Priority reviewMay 27, 2014
- Aloxi approved Aug 22, 2008
- Aloxi new use Feb 29, 2008
- Aloxi new use Feb 29, 2008
- Aloxi new use Aug 30, 2007
- Aloxi approved NovelJul 25, 2003
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (2)
Newest FDA action first.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.